| Vinod Goel (aged ~60 years) is a fellow member of the Institute of Company Secretaries of India and an associate member of the Institute of Cost Accountants of India. He holds B. Com (Hons.), M. Com, and LL. B degrees and has over 35 years of post-qualification experience in corporate governance, finance, legal, M&A, and corporate restructuring. He has been associated with Panacea Biotec since 1999 and currently serves as Group CFO and Head of Legal & Company Secretary.
Panacea Biotec is a research-based biotechnology companies engaged in the business of research, development, manufacture, and marketing of vaccines in India and international markets.
The company reported a consolidated net loss of Rs 13.92 crore in Q2 FY26 as against a net profit of Rs 4.80 crore in Q2 FY25. Revenue from operations declined 4.2% year on year to Rs 141.13 crore in Q2 FY25.
Shares of Panacea Biotec shed 0.67% to Rs 354.95 on the BSE. |